PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20054526-5	2010	METHODS: Fourteen CML patients were phenotyped for in vivo CYP3A activity using quinine as a probe drug.	Quinine	80-87	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	59-64	
20054526-6	2010	The plasma concentration ratio of quinine and its CYP3A metabolite was used for assessing CYP3A activity.	Quinine	34-41	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	90-95	
20054526-8	2010	RESULTS: Patients that achieved complete molecular response showed significantly (Mann-Whitney U-test, p=0.013) higher in vivo CYP3A activity (median quinine metabolic ratio = 10.1) than patients achieving partial molecular response (median = 15.9).	Quinine	150-157	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	127-132